Literature DB >> 23857404

Abscopal [corrected] effects after conventional and stereotactic lung irradiation of non-small-cell lung cancer.

Shankar Siva1, Jason Callahan, Michael P MacManus, Olga Martin, Rodney J Hicks, David L Ball.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23857404     DOI： 10.1097/JTO.0b013e318292c55a

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  29 in total

Review 1.  The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

Authors:  Kobe Reynders; Tim Illidge; Shankar Siva; Joe Y Chang; Dirk De Ruysscher
Journal:  Cancer Treat Rev       Date:  2015-03-28       Impact factor: 12.111

Review 2.  Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.

Authors:  Grainne M O'Kane; Natasha B Leighl
Journal:  Transl Lung Cancer Res       Date:  2016-12

3.  Abscopal regression following SABR for non-small-cell-lung cancer: A case report.

Authors:  Yang Cong; Ge Shen; Shikai Wu; Ruimin Hao
Journal:  Cancer Biol Ther       Date:  2016-12-06       Impact factor: 4.742

Review 4.  Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma.

Authors:  Anusha Kalbasi; Ramesh Rengan
Journal:  Transl Lung Cancer Res       Date:  2017-04

5.  Abscopal effect following radiation monotherapy in breast cancer: A case report.

Authors:  Ayaka Azami; Nobuyasu Suzuki; Yusuke Azami; Ichiro Seto; Atai Sato; Yoshinao Takano; Tsuyoshi Abe; Yasushi Teranishi; Kazunoshin Tachibana; Tohru Ohtake
Journal:  Mol Clin Oncol       Date:  2018-07-19

Review 6.  Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer.

Authors:  Howard J Lee; Jing Zeng; Ramesh Rengan
Journal:  Transl Lung Cancer Res       Date:  2018-04

Review 7.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

8.  Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer.

Authors:  Grit S Herter-Sprie; Shohei Koyama; Houari Korideck; Josephine Hai; Jiehui Deng; Yvonne Y Li; Kevin A Buczkowski; Aaron K Grant; Soumya Ullas; Kevin Rhee; Jillian D Cavanaugh; Neermala Poudel Neupane; Camilla L Christensen; Jan M Herter; G Mike Makrigiorgos; F Stephen Hodi; Gordon J Freeman; Glenn Dranoff; Peter S Hammerman; Alec C Kimmelman; Kwok-Kin Wong
Journal:  JCI Insight       Date:  2016-06-16

Review 9.  The current state of oligometastatic and oligoprogressive non-small cell lung cancer.

Authors:  Vasu Tumati; Puneeth Iyengar
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 10.  A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer.

Authors:  Zarique Z Akanda; Paul J Neeson; Thomas John; Stephen Barnett; Gerard G Hanna; Alistair Miller; Ross Jennens; Shankar Siva
Journal:  Transl Lung Cancer Res       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.